Status:
COMPLETED
Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study
Lead Sponsor:
Gunma University
Collaborating Sponsors:
J~pharma
Conditions:
Non-Small Cell Lung Cancer
Eligibility:
All Genders
20+ years
Brief Summary
L-\[3-18F\]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for positron emission tomography (PET). The aim of this study was to determine whether PET-CT with 18F-FMT provides additional informatio...
Eligibility Criteria
Inclusion
- Patients with indeterminate pulmonary nodule suspicious of lung cancer
Exclusion
- Patients with other malignancies and those who had received cancer treatment within the past 5 years were excluded.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00698373
Last Update
June 17 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.